536 related articles for article (PubMed ID: 3105322)
1. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
2. T-cell-rich lymphoproliferative disorders. Morphologic and immunologic differential diagnoses.
Winberg CD; Sheibani K; Burke JS; Wu A; Rappaport H
Cancer; 1988 Oct; 62(8):1539-55. PubMed ID: 2901904
[TBL] [Abstract][Full Text] [Related]
3. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
Strauchen JA; Breakstone BA
Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
[TBL] [Abstract][Full Text] [Related]
4. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
6. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
[TBL] [Abstract][Full Text] [Related]
7. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
8. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
[TBL] [Abstract][Full Text] [Related]
9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
10. Expression of Tac antigen by non-Hodgkin's lymphomas.
Weiss LM; Michie SA; Medeiros LJ; Strickler JG; Garcia CF; Warnke RA
Am J Clin Pathol; 1987 Oct; 88(4):483-5. PubMed ID: 2821794
[TBL] [Abstract][Full Text] [Related]
11. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
12. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte surface characteristics in malignant lymphoma.
Aisenberg AC; Long JC
Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
[TBL] [Abstract][Full Text] [Related]
14. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
Timens W; Visser L; Poppema S
Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD 25 (Tac antigen) in lymphoid leukemias and non-Hodgkin lymphomas.
Faure GC; Bene MC; Bolle-Chanal MH
Eur J Haematol; 1987 Jan; 38(1):26-30. PubMed ID: 3034662
[TBL] [Abstract][Full Text] [Related]
16. Clusterin expression in malignant lymphomas: a survey of 266 cases.
Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
[TBL] [Abstract][Full Text] [Related]
17. Expression of Tac antigen in B cell lymphomas.
Laurent G; Al Saati T; Olive D; Laurent JC; Poncelet P; Delsol G
Clin Exp Immunol; 1986 Aug; 65(2):354-62. PubMed ID: 3024885
[TBL] [Abstract][Full Text] [Related]
18. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
19. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
